Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer

Name: Olvi-Vec Oncolytic Immunotherapy in Patients With Recurrent or Refractory Ovarian Cancer
Published: 2016
License: Public Domain

Genelux Corporation · 2016

ClinicalTrials.gov · Datasets · License: Public Domain · 2016

Open Source ↗

immunotherapy ovarian-cancer

ovarian cancer, peritoneal carcinomatosis, fallopian tube cancer, olvi-vec, oncolytic virus, virotherapy, viral therapy, immunotherapy, immune therapy, vaccinia, vaccinia virus, genelux

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 879577
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.